Institution
Lincoln Hospital
Healthcare•New York, New York, United States•
About: Lincoln Hospital is a healthcare organization based out in New York, New York, United States. It is known for research contribution in the topics: Population & Emergency department. The organization has 1033 authors who have published 929 publications receiving 14486 citations. The organization is also known as: Lincoln Medical and Mental Health Center & Lincoln Hospital.
Topics: Population, Emergency department, Medicine, Poison control, Health care
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this article, the authors classified and described the different aspects of the treatment of tourniquet syndrome, and described a policy and procedure for the motorized removal of large bands by using a high revolutions per minute cutting device.
Abstract: A constricting band causing tourniquet syndrome is a common problem that can cause much frustration and pain for both the patient and practitioner. The following review classifies and describes the different aspects of the treatment of this condition. We also describe a policy and procedure for the motorized removal of large bands by using a high revolutions per minute cutting device.
24 citations
•
TL;DR: This report presents an unusual case of poisoning by the illegally imported rodenticide, “Tres Pasitos,” the main ingredient of which is aldicarb, a potent carbamate pesticide that causes fulminant cholinergic crisis.
Abstract: Rodenticides have historically been common agents in attempted suicides. As most rodenticides in the United States (U.S.) are superwarfarins, these ingestions are generally managed conservatively with close monitoring for coagulopathy, and if necessary, correction of any resulting coagulopathy. However, alternate forms of rodenticides are imported illegally into the U.S. and may be ingested either accidentally or in suicide attempts. We present an unusual case of poisoning by the illegally imported rodenticide, "Tres Pasitos." The main ingredient of this rat poison is aldicarb, a potent carbamate pesticide that causes fulminant cholinergic crisis. This case is relevant and timely because carbamates and organophosphates are still used as insecticides and emergency physicians (EP) working in rural areas may have to evaluate and manage patients with these poisonings. As international travel and immigration have increased, so has the possibility of encountering patients who have ingested toxic substances from other countries. In addition, there has been increased concern about the possibility of acts of terrorism using chemical substances that cause cholinergic toxidromes. EPs must be able to recognize and manage these poisonings. This report describes the mechanism of action, clinical manifestations, laboratory evaluation and management of this type of poisoning. The pertinent medical literature on poisoning with aldicarb and similar substances is reviewed. Language: en
23 citations
••
TL;DR: Corticotropin-releasing hormone may be an important biomarker for predicting PTB in minority women, especially when combined with other predictors.
Abstract: Objective To determine the predictive capability of corticotropin-releasing hormone (CRH) as a biomarker of preterm birth (PTB) in minority women. Study design Venous blood samples were obtained at 22-24 weeks' gestation in a prospective, descriptive study of 707 minority women experiencing low-risk pregnancies. CRH was analyzed using a radioimmunoassay and methanol extraction protocol. Result CRH predicted PTB in both African American and Hispanic women. The odds ratio was 1.8 times greater for having a PTB if the CRH level was >24 pg/ml. The median CRH for African American women having a PTB was 46.6 pg/ml and for Hispanic women was 35.03 pg/ml. Using a receiver-operating characteristic curve, the threshold for CRH among the African American women was 30.6 pg/ml and among the Hispanic women was 27.4 pg/ml. Conclusion CRH may be an important biomarker for predicting PTB in minority women, especially when combined with other predictors.
23 citations
••
TL;DR: A case of a middle-aged man with multiple co-morbidities, who was diagnosed with COVID-19 and acute appendicitis, who received intravenous antibiotics for seven days with a significant improvement in symptoms is reported.
Abstract: Appendectomy is the gold standard of treatment for acute appendicitis;however, recent evidence suggests conservative management with intravenous antibiotics may provide similar outcomes and can be used as an alternative in selected patients Performing appendectomy in acute appendicitis patients with 2019 novel Coronavirus Disease (COVID-19) is challenging, as it involves considerable operative risks for the patients and risks for health care professionals (HCPs) exposed to COVID-19 Medical management eliminates the morbidity and mortality associated with surgery but involves significant risks of treatment failures that, in turn, may lead to perforation, peritonitis, and death We are reporting a case of a middle-aged man with multiple co-morbidities, who was diagnosed with COVID-19 and acute appendicitis Our patient received intravenous antibiotics for seven days with a significant improvement in symptoms Our case report illustrates the implementation of successful conservative treatment for acute appendicitis in COVID-19 patients
23 citations
••
TL;DR: DDAVP was associated with a lower incidence of hematoma expansion in patients with mild TBI who were prescribed pre-injury antiplatelet medications, which justifies a randomized controlled trial to further evaluate the role of DDAVP for this indication.
Abstract: Desmopressin (DDAVP) has been suggested for antiplatelet medication reversal in patients with traumatic brain injury (TBI) but there are limited data describing its effect on clinical outcomes. The purpose of this study was to evaluate the effect of DDAVP on hematoma expansion and thrombosis in patients with TBI who were prescribed pre-injury antiplatelet medications. Consecutive adult patients who were admitted to our level I trauma center and prescribed pre-injury antiplatelet medications between July, 2012, and May, 2018, were retrospectively identified. Patients were excluded if their hospital length of stay was 81 mg), ADP-receptor inhibitors, oral anticoagulants, prothrombin complex concentrates or platelets in a multivariate analysis, the association between DDAVP and hematoma expansion remained significant (adjusted OR 0.259 [95% CI 0.103–0.646], p = 0.004). Thrombotic events were similar between the two groups (DDAVP, 2.5%, no DDAVP, 4.5%; p = 0.613). DDAVP was associated with a lower incidence of hematoma expansion in patients with mild TBI who were prescribed pre-injury antiplatelet medications. These results justify a randomized controlled trial to further evaluate the role of DDAVP for this indication.
23 citations
Authors
Showing all 1035 results
Name | H-index | Papers | Citations |
---|---|---|---|
Gbenga Ogedegbe | 61 | 333 | 17984 |
Kathryn Anastos | 59 | 351 | 13391 |
Marios Loukas | 54 | 885 | 13823 |
Sharon Nachman | 47 | 180 | 7199 |
Stephen J. Peterson | 34 | 118 | 3778 |
Miklos F. Losonczy | 31 | 65 | 3057 |
Stephen T. Chasen | 30 | 163 | 2855 |
Theodore J. Gaeta | 28 | 78 | 3239 |
Vikram Paruchuri | 23 | 43 | 1863 |
Henrietta Kotlus Rosenberg | 23 | 96 | 1622 |
Enrica Marchi | 22 | 76 | 1968 |
Harsh Grewal | 22 | 63 | 1448 |
R. R. Ivatury | 21 | 33 | 1956 |
Alicia Mangram | 21 | 55 | 1177 |
Edward J. Brown | 20 | 46 | 6877 |